FoRx Therapeutics
Phase 1Next-Generation Therapeutics FoRx Therapeutics is a privately held clinical-stage biotechnology company pioneering precision therapeutics targeting DNA Replication Stress in treatment-resistant cancers. FoRx is developing first- and best-in-class compounds for cancer treatment by focusing on drugging key molecular targets involved in DNA replication stress, a new approach towards the development of targeted anticancer drugs. Our team […]
About
Next-Generation Therapeutics FoRx Therapeutics is a privately held clinical-stage biotechnology company pioneering precision therapeutics targeting DNA Replication Stress in treatment-resistant cancers. FoRx is developing first- and best-in-class compounds for cancer treatment by focusing on drugging key molecular targets involved in DNA replication stress, a new approach towards the development of targeted anticancer drugs. Our team […]
Funding History
2Total raised: $37M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile